DEA Houston warns of synthetic opioid hitting Houston and surrounding areas
DEA Houston warns of the synthetic opioid Nitazene, saying it's 25% more potent than fentanyl.
DEA Houston says they have seen a major increase in overdoses and seizures in the last year.
A mother who lost her son to fentanyl is advocating for change and shares her message for families.
HOUSTON - The Houston field office for the Drug Enforcement Agency (DEA) is putting out a serious and stern warning about a synthetic drug called Nitazene that's leading to seizures and overdoses in teens and adults.
What they're saying
The DEA says Harris, Fort Bend, Montgomery and Brazoria County have all been impacted by Nitazene, which is 25% more potent than fentanyl.
Special Agent William Kimbell with the DEA says Nitazene, a killer synthetic drug, has been in our area since 2022.
"In the last year, we've become more and more concerned because our number of seizures have gone up in between November and February of this year. We have had a 15% increase of overdoses from Nitazene in Houston," said Special Agent Kimbell. "Nitazene is a typical opioid. It suppresses your breathing, it suppresses your blood pressure, and your body is so suppressed, you can't breathe anymore."
Special Agent Kimbell says the drug is impacting people in a wide age range.
"We've seen overdoses now from the ages of 17 to 59, so really. If you are buying a pill from someone you don't know, or you are using a pill that you don't know where it came from, it could have Ntazene in it and it's extremely dangerous," said Special Agent Kimbell, "Its synthetic route is very hard to make, and you need lab experience, but we are seeing Nitazene that are made in China, and they are purchased online and smuggled into the US in parcels, and locally, we are seeing drug gangs take fentanyl and Nitazene and pressing it into a what looks like a prescription drug."
Why you should care
Special Agent Kimbell says Nitazene can be purchased online, using a smartphone.
He says, sadly, that's how many kids are getting their hands on it.
"We are seeing kids carry that – they can reach a drug dealer that is carrying this type of drug instantly," he said. "Within minutes you can tuck your kids in bed, and they can get on social media, and they can have that stuff delivered to their house."
Local perspective
Stephanie Roe, who lost her son Tucker at 19 to fentanyl in 2021, has a warning to families and raising awareness through Texas Against Fentanyl.
"I watched this come into his life and be introduced as an adolescent, and he couldn't beat it. Ultimately, he used again after his treatment and that resulted in his death," said Roe," Nitazene are incredibly lethal. They have been found to be 20 times stronger than Fentanyl.
Roe says it's important for families to talk to their kids and learn more about drug addiction, adding there is a real stigma that needs to be talked about.
"The drug demographic is unlike anything we have seen before and these are highly addictive chemicals," Roe said," "You don't think it will happen to our child if you asked me if I would be someone who would lose a child" I would say no way, but the reality is there is no demographic here, its impacting so many people because there is a lack of education and awareness."
The Source
FOX 26 reporter Leslie DelasBour spoke with Special Agent William Kimbell of the Houston Drug Enforcement Agency and Stephanie Roe, who lost her son to a fentanyl overdose.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
26 minutes ago
- Fox News
Extra: How A ‘Fentanyl Father' Turned His Grief Into Activism
While there appears to be some progress in America's war on fentanyl, overdose deaths related to the synthetic drug remain alarmingly high, especially among young people. President Trump recently signed the HALT Fentanyl Act, expanding law enforcement's ability to crack down on traffickers. Gregory Swan lost his son, Drew, to a fentanyl overdose in 2013. Since then, he has co-founded Fentanyl Fathers and devoted his life to raising awareness about the lethal drug. Gregory recently spoke with FOX News Rundown host David Anthony to share his personal story, discuss the HALT Fentanyl Act, and explain how he is working with families to help them avoid the loss he and so many other parents have felt. We often have to cut interviews short during the week, but we thought you might like to hear the full interview. Today on Fox News Rundown Extra, we will share our entire interview with Gregory Swan, allowing you to hear more about how he turned his grief into activism. Learn more about your ad choices. Visit
San Francisco Chronicle
12 hours ago
- San Francisco Chronicle
No, California is not guaranteed to remain an abortion haven
The sudden closure of five Planned Parenthood clinics in Northern California last week reveals a sad, stark truth: California is not the national 'haven' for abortion rights that it has aspired to be since the Supreme Court overturned Roe v. Wade in 2022. No state could be under Republican rule in Washington, or while federal law trumps state law, the Supreme Court majority opposes abortion rights and clinics are reliant on federal money to survive. There are few options to fix this problem, even in California, the world's fourth-largest economy. The state barely covered its budget deficit this year, and it has holes to fill as federal funds for public universities, education, transportation and other sectors were slashed in the recently passed budget. Plus, the state needs federal dollars to help rebuild Los Angeles after the devastating wildfires there earlier this year. Ten million Americans are expected to lose their health insurance because of nearly $1 trillion in Medicaid cuts over the next decade in the One Big Beautiful Bill Act, according to the nonpartisan Congressional Budget Office. Meanwhile, the wealthiest Americans will receive a disproportionate share of the tax cuts funded by those reductions, according to the Center for Budget and Policy Priorities. 'It's an illustration of the limits on what any state can do (on abortion access) if the federal government is hostile,' said Mary Ziegler, a professor of law at UC Davis and leading scholar on abortion rights. 'It's more of a reminder that there isn't really a real sanctuary. California has limited power over a lot of this.' It is the latest example of how California is in the political crosshairs of what President Donald Trump's former top adviser Steve Bannon famously described as his 'muzzle velocity' philosophy of launching a lot of disruptive policies and spurious attacks simultaneously. California is withering under the incoming fire. The people hurt most by the closure of those clinics will be the poorest Californians, as 80% of the people who used services at those clinics were Medicaid recipients, according to Planned Parenthood Mar Monte, the umbrella organization for the shuttered clinics. Planned Parenthood doesn't just provide abortion services. The majority of people go to Planned Parenthood clinics for contraceptive services, sexually transmitted infection testing, pregnancy testing and gynecological services. One in 10 (11%) female Medicaid beneficiaries ages 15 to 49 who received family planning services went to a Planned Parenthood clinic in 2021, according to the nonpartisan Kaiser Family Foundation. California has the highest percentage (29%) of Medicaid recipients in the country who go there for health care. This wasn't the way it was supposed to go. California was supposed to be a haven for abortion rights after the Supreme Court overturned Roe v. Wade. Shortly after the decision, Gov. Gavin Newsom joined the governors of Washington and Oregon to create what he called 'the West Coast offensive. A road map for other states to stand up for women.' A diverse coalition of abortion rights advocates formed the California Future of Abortion Council. It proposed more than 50 recommendations for policymakers to improve abortion access in the state. In the year after the decision, Newsom and the Democratic-controlled Legislature created more than a dozen new laws and invested more than $200 million to increase access across the state. In November 2022, 67% of California voters supported a ballot measure enshrining abortion rights in the state Constitution. Newsom spent $100,000 from his campaign coffers to plant billboards in seven states with some of the nation's most restrictive laws: 'Need an abortion?' reads one billboard. 'California is here to help.' 'What you do in California sets the standard for everyone else,' Mini Timmaraju, national president of NARAL Pro-Choice America, said at a 2022 fundraiser for Proposition 1 in San Francisco that Hillary Clinton attended. 'I want to take that package of legislation and this proposition and see it copied nationwide.' Ultimately, all those California laws and all that state funding weren't enough to keep the Mar Monte clinics open. They never could be as long as there isn't the national right to an abortion that Roe provided and as long as women's health clinics are reliant on federal funds to remain open. Planned Parenthood estimates that 200 clinics nationwide could close. To meet this reality, California needs a new 'West Coast offensive.' It needs to draw up a new 'road map for other states to stand up for women.' It would be best if clinics were funded privately, insulating them from partisan federal cuts. But that is harder now. California is the state with the most millionaires and billionaires. Now is the time for wealthy individuals and foundations to stand up and backfill these losses so clinics can continue to provide access to women's health care. But will those individuals step forward? Or will they be cowed like the wealthy law firms and Ivy League universities that have bowed to Trump's intimidation? Even if they do step up, is there enough private money in California to keep federally funded women's health clinics open until Democrats regain control of at least one lever of power in Washington and can curb his fascistic policies? That possibility looks bleak. For starters, it would probably require hundreds of millions of dollars, said Shannon Olivieri Hovis, former NARAL Pro-Choice California director who is now vice president of public affairs at Essential Access Health. 'I think the honest answer is, we don't know yet. We're talking about a huge hole.' Theresa Cheng, a professor of emergency medicine at UCSF and a member of the school's Bixby Center for Global Reproductive Health, said it will be difficult for the private sector to patch up all the new holes punctured in the social safety net by the Trump administration. 'That's going to be really difficult because the Trump administration has cut so broadly in so many social systems,' said Cheng, who is in touch with private donors through her work with several nonprofit organizations. 'Food insecurity. Homelessness. Immigration. There are a lot of needs out there now.' Relying on private donations isn't going to help clinics across California's chasm of wealth inequality, Ziegler said. 'If you're depending partly on individual donors, that's going to look very different in Beverly Hills or Marin County than it is in Gilroy or other areas where there are few people to give private donations,' Ziegler said. Until political change happens in Washington, Cheng urged Californians to 'stay stalwart in protecting reproductive health. So much of this will have to be settled out in the courts. That will at least buy us some more time.'
Yahoo
14 hours ago
- Yahoo
DEA Scrambles to Defend Marijuana Decision Amid Supreme Court Ruling, Legal Collapse And Public Outrage
"This Wasn't DEA Marijuana Regulation - It Was a DEA Illegal Ambush." ALL EYES ON TERRY COLE!MMJ BioPharma Cultivation CEO Duane Boise is calling out the DEA's desperate attempt to defend a marijuana Administrative Law Judge decision that never got a hearing, blocked marijuana scientific evidence, and defied Supreme Court precedent. "They're defending a hearing that never actually happened," said Duane Boise."We followed every rule. They followed none." WASHINGTON, D.C. / / July 27, 2025 / Friday, the U.S. Drug Enforcement Administration (DEA) filed a last-minute response in an escalating legal battle with MMJ BioPharma Cultivation, a Rhode Island-based pharmaceutical company seeking to grow federally compliant cannabis for FDA-approved clinical trials targeting Huntington's Disease and Multiple Sclerosis. The agency's filing comes in response to MMJ's official legal "exceptions" challenging a controversial ruling by DEA Chief Administrative Law Judge John Mulrooney II (aka Mclooney) - a ruling that denied MMJ's bulk manufacturing registration without a hearing, without cross-examination, and without admitting material evidence into the record. "We were stonewalled at every step," said Duane Boise, CEO of MMJ BioPharma. "The DEA ignored Supreme Court precedent, blocked our science, and manipulated the process to produce a predetermined outcome. Now they're trying to defend that decision in a system the Department of Justice itself has declared unconstitutional." Constitutional Crisis MMJ's case has become a flashpoint in the broader collapse of the DEA's internal court system. In Axon v. FTC (2023) and Jarkesy v. SEC (2024), the U.S. Supreme Court ruled that agency administrative law judges (ALJs) violate the separation of powers because they are insulated from presidential removal - a direct hit to the DEA's current process. Even the Department of Justice has abandoned its defense of the ALJ structure, and Attorney General Pam Bondi notified the courts in February 2025 that DEA hearings like the one against MMJ BioPharma Cultivation are legally void. DEA's Desperate Defense Despite this, the DEA has now used its one allotted legal filing to respond to MMJ's exceptions - an effort seen by legal experts as a last-ditch attempt to salvage a crumbling decision and maintain bureaucratic control over cannabis based drug development. "This is the DEA doubling down on injustice," said Boise. "They're defending a hearing that never actually happened because they're afraid of what the truth will show." A Legitimate Researcher, Blocked MMJ BioPharma Cultivation is not a dispensary. It is a federally compliant manufacturer that has: FDA Orphan Drug Designation Two accepted Investigational New Drug (IND) applications A pharmaceutical grade cannabis facility built to DEA standards Binding supply agreements with Schedule I licensees Yet after more than 2,400 days of delays, the DEA still refuses to approve its registration - while unlicensed tribal and cartel-linked marijuana networks operate with impunity across state lines, and recreational cannabis companies receive preferential treatment. Path Forward: Will Administrator Terrance Cole Act? All eyes now turn to Terrance Cole, President Trump's newly confirmed DEA Administrator, who holds the final authority to approve or deny MMJ's license. "Administrator Cole has a choice," said Boise. "He can defend a broken system riddled with bias and constitutional violations-or he can restore integrity by granting our lawful, science backed registration and ending seven years of obstruction." MMJ BioPharma has vowed to take its case as far as necessary, including seeking federal injunctions and legislative reform if the DEA continues to block research. About MMJ BioPharma Cultivation MMJ BioPharma is a federally compliant biopharmaceutical company focused on producing cannabis derived medicines for neurodegenerative diseases. It operates under FDA regulatory frameworks and maintains partnerships with international GMP manufacturers and licensed U.S. laboratories. MMJ is represented by attorney Megan Sheehan. CONTACT:Madison HiseyMHisey@ SOURCE: MMJ International Holdings View the original press release on ACCESS Newswire
